51. One percent of drugs with Medicaid reimbursement were not FDA-approved Publication: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, May 2019 Subject(s): Drug ApprovalInsurance, Health, Reimbursement -- economicsInsurance, Health, Reimbursement -- statistics & numerical dataMedicaid -- economicsMedicaid -- statistics & numerical dataEconomics, PharmaceuticalFraud -- prevention & controlPrescription Drugs -- economicsHumansUnited StatesUnited States. Food and Drug Administration.